%0 Journal Article
%A Scuteri, Damiana
%A Pagliaro, Martina
%A Mantia, Isabel
%A Contrada, Marianna
%A Pignolo, Loris
%A Tonin, Paolo
%A Nicotera, Pierluigi
%A Bagetta, Giacinto
%A Corasaniti, Maria Tiziana
%T Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial.
%J Frontiers in pharmacology
%V 15
%@ 1663-9812
%C Lausanne
%I Frontiers Media
%M DZNE-2024-01043
%P 1417851
%D 2024
%X An estimated 57.4 million people live with dementia worldwide, with the social burden of the disease steadily growing. Despite the approval of lecanemab and ongoing trials, there is still a lack of effective and safe treatments for behavioral and psychological symptoms of dementia (BPSD), which affect 99
%K BRAINAID (Other)
%K NCT04321889 (Other)
%K NanoBEO (Other)
%K agitation (Other)
%K behavioural and psychological symptoms of dementia (Other)
%K dementia (Other)
%K pain (Other)
%K pilot clinical trial (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:39148533
%2 pmc:PMC11325727
%R 10.3389/fphar.2024.1417851
%U https://pub.dzne.de/record/271342